Multi-omics insights reveal new drivers of organ damage in Fabry disease
Peer-Reviewed Publication
Updates every hour. Last Updated: 25-Oct-2026 10:17 ET (25-Oct-2026 14:17 GMT/UTC)
A comprehensive review is shedding new light on Fabry disease, a rare inherited disorder that can progressively damage multiple organs and significantly affect quality of life. The article highlights how advances in multi-omics technologies, including transcriptomics, proteomics, and metabolomics, are expanding understanding of the biological processes that drive organ injury and opening new possibilities for earlier diagnosis and more personalized treatment.
Scientists are shedding new light on a little-known biological system that could help unlock the full potential of stem cell therapy, one of the most promising areas of modern medicine. A new review highlights the growing importance of PIWI proteins and PIWI-interacting RNAs (piRNAs), a specialized class of small RNA molecules that play a central role in controlling how stem cells maintain their identity, repair tissues, and develop into specialized cell types.
A comprehensive new review is bringing together the latest advances in Ménière’s disease, offering a clearer picture of the biological mechanisms that may drive this complex inner ear disorder while highlighting new directions for diagnosis, disease modeling, and treatment. The article proposes that the endolymphatic sac, a structure involved in maintaining the inner ear environment, may represent the central site where multiple disease-triggering factors converge, providing a unifying explanation for the diverse symptoms experienced by patients.
A growing body of evidence suggests that a rare epithelial cell type known as the tuft cell may play a far more significant role in cancer than previously recognized. A recent review proposes that tumors expressing the tuft cell master regulator POU2F3 represent a distinct molecular class of “tuft cell-like” cancers spanning multiple organs, including the lung, pancreas, stomach, colon, breast, prostate, and neuroendocrine tissues. These tumors exhibit unique biological characteristics that may create new opportunities for diagnosis, prognosis, and targeted therapy.
The global rise in obesity and population aging represents a major public health challenge, with growing evidence suggesting that excess body fat not only increases the risk of chronic disease but may also accelerate the biological aging process. A new review examines the close relationship between obesity and aging, highlighting the overlapping molecular mechanisms that link the two conditions and exploring whether anti-obesity therapies could help slow aging and reduce age-related disease.
A growing understanding of RNA biology is reshaping how scientists view the relationship between environmental toxicants, brain development, and neurodegenerative disease. A new review highlights the emerging importance of N6-methyladenosine (m6A), the most common RNA modification in cells, as a key regulator of nervous system development and a potential contributor to neurological damage caused by toxic environmental exposures.
A recent review explores the rapidly expanding field of ferroptosis-based therapy for prostate cancer, presenting ferroptosis as a promising strategy to overcome resistance in advanced and castration-resistant prostate cancer (CRPC). The authors synthesize current knowledge of ferroptosis mechanisms, biomarkers, therapeutic agents, combination strategies, and translational challenges, proposing a framework that links ferroptosis regulatory networks with precision medicine approaches.
Drug resistance remains one of the greatest obstacles to successful treatment of gastric cancer, limiting the long-term effectiveness of the widely used chemotherapy drug cisplatin. A new review highlights autophagy, the natural process by which cells recycle damaged proteins and organelles, as a promising therapeutic target that could improve treatment responses and help overcome resistance to chemotherapy.